Cas:87827-55-2 alismol manufacturer & supplier

We serve Chemical Name:alismol CAS:87827-55-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

alismol

Chemical Name:alismol
CAS.NO:87827-55-2
Synonyms:alismol;guaianediol;(1R,3aS,8aR)-7-Isopropyl-1-methyl-4-methylene-1,2,3,3a,4,5,6,8a-octahydro-1-azulenol;1-Azulenol, 1,2,3,3a,4,5,6,8a-octahydro-1-methyl-4-methylene-7-(1-methylethyl)-, (1R,3aS,8aR)-
Molecular Formula:C15H24O
Molecular Weight:220.350
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:316.8±21.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.513
PSA:20.23000
Exact Mass:220.182709
LogP:4.77

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like alismol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Azulenol, 1,2,3,3a,4,5,6,8a-octahydro-1-methyl-4-methylene-7-(1-methylethyl)-, (1R,3aS,8aR)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,guaianediol Use and application,1-Azulenol, 1,2,3,3a,4,5,6,8a-octahydro-1-methyl-4-methylene-7-(1-methylethyl)-, (1R,3aS,8aR)- technical grade,usp/ep/jp grade.


Related News: Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. alismol manufacturer Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. alismol supplier Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients. alismol vendor First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. alismol factory Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients.